AccessHope has unveiled new research that demonstrates how remote expert oncology opinions can meaningfully bridge socioeconomic and geographic barriers to facilitate optimal cancer care.
As of Oct. 1, Medicare no longer covers telehealth visits.
Telemedicine consults lead to changes in treatment in half of cases, study finds
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
In honor of Hispanic Heritage Month, this week’s episode of The Cancer Letter Podcast features three oncology leaders whose research focuses on identifying and solving health disparities specifically in the Latinx community.
We are rapidly approaching the Sept. 30 planned expiration of telemedicine coverage under Medicaid. Letting this authorization expire is short-sighted. As an oncologist, I believe there are multiple compelling, non-pandemic reasons for telemedicine to remain a permanent fixture in cancer care.
The fight against lung cancer is evolving, with groundbreaking research shedding light on the intricate interplay between biology, environment, and health disparities.
A telehealth partnership between Intermountain Health and the Tanana Chiefs Conference is bringing broad access to greatly needed cancer services due in a remote area of Fairbanks, Alaska.
The Ohio State University Comprehensive Cancer has launched a first-of-its-kind clinical trial.
